Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A Robins

Showing results (31-40 of 129) with videos related to

Pageof 13
Sort By:
The British Journal of Cancer. Supplement|August 1, 1973
Significance of serum factors modifying cellular immune responses to growing tumoursR W Baldwin, M R Price, R A Robins
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Capture of recombinant ricin A chain by a bispecific anti-RTA:anti-CEA monoclonal antibody pre-targeted to a human gastric carcinoma xenograft in nude miceM V Pimm, R A Robins, R W Baldwin
International Journal of Cancer|July 9, 1993
Development of an anti-idiotypic antibody reactive with an antibody defining the epitope RPAP in the MUC-1 epithelial mucin coreJ L Bashford, R A Robins, M R Price
Cellular Immunology|July 1, 1982
Rat lymphocyte subsets: cellular requirements for the generation of T-cell growth factorD A Cantrell, R A Robins, R W Baldwin
Nature: New Biology|August 9, 1972
Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexesR W Baldwin, M R Price, R A Robins
Pediatric Research|January 1, 1981
Procoagulant activity of human mononuclear leukocytes: dissociation of the effect of mitogens on procoagulant activity and mitogen-stimulated lymphocyte proliferationK C Rich, R A Robins, E R Stiehm
Cellular Immunology|June 1, 1981
Natural killer cells infiltrate transplanted chemically induced sarcomasG R Flannery, R A Robins, R W Baldwin
British Journal of Cancer|December 1, 1979
Tumour-derived lymphoid cells prevent tumour growth in Winn assaysR A Robins, G R Flannery, R W Baldwin
Journal of the National Cancer Institute|May 3, 1989
Flow cytometric screening of monoclonal antibodies for drug or toxin targeting to human cancerL G Durrant, R A Robins, R W Baldwin
Immunology Today|June 26, 1998
Tumour immunology: false hopes--new horizons?A B Alexandroff, R A Robins, A Murray, et al.
Pageof 13

Showing results (31-40 of 129) with videos related to

Sort By:
Pageof 13
The British Journal of Cancer. Supplement|August 1, 1973
Significance of serum factors modifying cellular immune responses to growing tumoursR W Baldwin, M R Price, R A Robins
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Capture of recombinant ricin A chain by a bispecific anti-RTA:anti-CEA monoclonal antibody pre-targeted to a human gastric carcinoma xenograft in nude miceM V Pimm, R A Robins, R W Baldwin
International Journal of Cancer|July 9, 1993
Development of an anti-idiotypic antibody reactive with an antibody defining the epitope RPAP in the MUC-1 epithelial mucin coreJ L Bashford, R A Robins, M R Price
Cellular Immunology|July 1, 1982
Rat lymphocyte subsets: cellular requirements for the generation of T-cell growth factorD A Cantrell, R A Robins, R W Baldwin
Nature: New Biology|August 9, 1972
Blocking of lymphocyte-mediated cytotoxicity for rat hepatoma cells by tumour-specific antigen-antibody complexesR W Baldwin, M R Price, R A Robins
Pediatric Research|January 1, 1981
Procoagulant activity of human mononuclear leukocytes: dissociation of the effect of mitogens on procoagulant activity and mitogen-stimulated lymphocyte proliferationK C Rich, R A Robins, E R Stiehm
Cellular Immunology|June 1, 1981
Natural killer cells infiltrate transplanted chemically induced sarcomasG R Flannery, R A Robins, R W Baldwin
British Journal of Cancer|December 1, 1979
Tumour-derived lymphoid cells prevent tumour growth in Winn assaysR A Robins, G R Flannery, R W Baldwin
Journal of the National Cancer Institute|May 3, 1989
Flow cytometric screening of monoclonal antibodies for drug or toxin targeting to human cancerL G Durrant, R A Robins, R W Baldwin
Immunology Today|June 26, 1998
Tumour immunology: false hopes--new horizons?A B Alexandroff, R A Robins, A Murray, et al.
Pageof 13